Show Notes
In this episode, we’re looking at the unique approach France has taken to try and get new and innovative treatments to patients faster, and what other national health bodies could learn from this process.
Joining us is an expert in market access and health policy, who has been at the forefront of recent regulatory changes in France and brings with her a wealth of knowledge from a career spanning three decades in pharmaceuticals.
This recording was organised and funded by Johnson & Johnson June 2024 CP-460651 Hosted on Acast. See acast.com/privacy for more information.
More from Transforming Health
In this episode, we explore why health should be seen as an investment, that delivers positive returns for individuals, economies and society as a whole.
This episode focuses on precision medicine in cancer – why it’s considered so revolutionary, and how we can work together to make it more accessible to every patient.
In this episode, our experts shine a light on the benefits of endoscopy in the long-term management of inflammatory bowel disease (IBD).
In this episode, we talk about the importance of shared decision-making in helping patients achieve a “life of possibility”, especially in complex illnesses like multiple myeloma.
In the final episode of Season 2, we look at the future of healthcare in Central Europe and the Baltics, a diverse region that covers almost one third of EU countries.